Callahan Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Callahan Advisors's LLY Position: Q1 2026 in Review
Callahan Advisors increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $1.01M and bringing the position to 20,163 shares worth $18.5M. The position accounts for 1.55% of the portfolio, ranked #22.
Callahan Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $20.6M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Callahan Advisors held 20,163 shares of Eli Lilly worth $18.5M as of Q1 2026.
- Callahan Advisors bought 1,001 Eli Lilly shares in Q1 2026, an estimated $1.01M.
- Eli Lilly made up 1.55% of Callahan Advisors's portfolio in Q1 2026, its #22 holding.
- Callahan Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Callahan Advisors's Eli Lilly position peaked at $20.6M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.